Revvity Blog
Powering innovation from discovery to cure.
Latest
How conditional bispecific antibodies are advancing precision immunotherapy.
Cancer
August 14, 2025 - 2 min read
Disease Research, Drug Development, Precision Medicine
What to consider when selecting a centrifuge for your lab.
January 24, 2025 -
3 min read
Drug Development, Small Molecule Drug Discovery
How to leverage automation of tissue homogenization to address sample prep challenges in drug discovery & development.
August 8, 2024 -
2 min read
Drug Development
Antibody detection provides insights into long-term viral immunity and the efficacy of vaccines.
July 11, 2024 -
3 min read
Drug Development
Revolutionizing predictive toxicology testing with organ-on-chip models.
June 19, 2024 -
2 min read
Drug Development
Drug repurposing for antiviral therapies: research and strategies with high throughput screening.
May 29, 2024 -
2 min read
Disease Research, Cancer, Drug Development
Why use fluorescent probes in your in vivo imaging studies?
April 9, 2024 -
3 min read
Disease Research, Drug Development
Seven steps to designing an effective in vivo fluorescence imaging study.
April 3, 2024 -
2 min read
Disease Research, Drug Development
In vivo imaging study highlights potential for non-invasive evaluation of NASH.
April 3, 2024 -
2 min read
Drug Development
Revvity Omics: expertise in drug development, from inception to market.
March 25, 2024 -
3 min read